Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-12-06 Sale | 2023-12-07 4:51 pm | TherapeuticsMD Inc. | TXMD | Walker Marlan D Chief Executive Officer | 19,050 | $2.2931 | $43,684 | 62,565 (Direct) | View |
| 2023-04-26 Sale(A) | 2023-05-04 4:38 pm | TherapeuticsMD Inc. | TXMD | Walker Marlan D Chief Executive Officer | 692 | $3.6381 | $2,518 | 15,081 (Direct) | View |
| 2023-04-12 Sale | 2023-04-14 7:20 pm | TherapeuticsMD Inc. | TXMD | Walker Marlan D Chief Executive Officer | 1,170 | $3.6543 | $4,276 | 19,239 (Direct) | View |
| 2023-01-26 Sale | 2023-01-30 6:40 pm | TherapeuticsMD Inc. | TXMD | Donegan Michael C Prin. Fin. and Acctg. Officer | 1,697 | $5.0799 | $8,621 | 11,853 (Direct) | View |
| 2023-01-23 Sale | 2023-01-25 5:50 pm | TherapeuticsMD Inc. | TXMD | Donegan Michael C Prin. Fin. and Acctg. Officer | 1,309 | $5.3381 | $6,988 | 7,610 (Direct) | View |
| 2022-12-09 Purchase | 2022-12-12 11:14 am | TherapeuticsMD Inc. | TXMD | Rubric Capital Management LP Rosen David Efraim 10% Owner | 14,825 | $6.09 | $90,284 | 1,757,191 (Indirect) | View |
| 2022-12-06 Sale | 2022-12-09 7:41 pm | TherapeuticsMD Inc. | TXMD | Bernick Brian Co-Chief Executive Officer | 1,255 | $5.2761 | $6,621 | 49,596 (Indirect Direct) | View |
| 2022-12-06 Sale | 2022-12-09 7:38 pm | TherapeuticsMD Inc. | TXMD | Walker Marlan D General Counsel | 1,048 | $4.9475 | $5,185 | 10,776 (Direct) | View |
| 2022-12-06 Sale | 2022-12-09 7:38 pm | TherapeuticsMD Inc. | TXMD | Glickman Mark A Co-Chief Executive Officer | 440 | $4.9215 | $2,165 | 4,760 (Direct) | View |
| 2022-12-06 Sale | 2022-12-09 7:37 pm | TherapeuticsMD Inc. | TXMD | Donegan Michael C Interim CFO/CAO/VP of Finance | 910 | $4.775 | $4,345 | 6,519 (Direct) | View |
| 2022-12-07 Purchase | 2022-12-09 10:58 am | TherapeuticsMD Inc. | TXMD | Rubric Capital Management LP Rosen David Efraim 10% Owner | 20,413 | $5.665 | $115,639 | 1,742,366 (Indirect) | View |
| 2022-12-07 Sale | 2022-12-08 8:10 pm | TherapeuticsMD Inc. | TXMD | Naughton Gail K Director | 3,922 | $5.2614 | $20,635 | 0 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-12-05 Exercise | 2023-12-07 4:51 pm | N/A N/A | TherapeuticsMD Inc. | TXMD | Walker Marlan D Chief Executive Officer | 70,000 | $0 | 62,565 (Direct) | View |
| 2023-11-15 Option Award | 2023-11-17 09:27 am | N/A N/A | TherapeuticsMD Inc. | TXMD | Rubric Capital Management LP Rosen David Efraim See Remarks. 10% Owner | 877,192 | $2.28 | 2,946,908 (Indirect) | View |
| 2023-08-17 Option Award | 2023-08-21 4:22 pm | N/A N/A | TherapeuticsMD Inc. | TXMD | ZIEGLER JOSEPH Principal Financial Officer | 7,500 | $0 | 7,500 (Direct) | View |
| 2023-07-17 Option Award | 2023-07-19 5:29 pm | N/A N/A | TherapeuticsMD Inc. | TXMD | Thompson Tommy G Director | 8,500 | $0 | 8,500 (Direct) | View |
| 2023-07-17 Option Award | 2023-07-19 5:28 pm | N/A N/A | TherapeuticsMD Inc. | TXMD | Naughton Gail K Director | 8,500 | $0 | 8,500 (Direct) | View |
| 2023-07-17 Option Award | 2023-07-19 5:27 pm | N/A N/A | TherapeuticsMD Inc. | TXMD | Collins Cooper C. Director | 8,500 | $0 | 8,500 (Direct) | View |
| 2023-06-28 Option Award | 2023-06-29 5:21 pm | N/A N/A | TherapeuticsMD Inc. | TXMD | Rubric Capital Management LP Rosen David Efraim See Remarks 10% Owner | 312,525 | $3.6797 | 2,069,716 (Indirect) | View |
| 2023-04-26 Exercise(A) | 2023-05-04 4:38 pm | N/A N/A | TherapeuticsMD Inc. | TXMD | Walker Marlan D Chief Executive Officer | 2,744 | $0 | 15,081 (Direct) | View |
| 2023-04-12 Exercise | 2023-04-14 7:20 pm | N/A N/A | TherapeuticsMD Inc. | TXMD | Walker Marlan D Chief Executive Officer | 7,508 | $0 | 19,239 (Direct) | View |
| 2023-04-12 Exercise | 2023-04-14 7:17 pm | N/A N/A | TherapeuticsMD Inc. | TXMD | Donegan Michael C Prin. Fin. and Acctg. Officer | 50,000 | $0 | 61,853 (Direct) | View |
| 2023-02-21 Option Award | 2023-02-23 5:16 pm | N/A N/A | TherapeuticsMD Inc. | TXMD | Walker Marlan D Chief Executive Officer | 70,000 | $0 | 70,000 (Direct) | View |
| 2023-02-21 Option Award | 2023-02-23 5:11 pm | N/A N/A | TherapeuticsMD Inc. | TXMD | Donegan Michael C Prin. Fin. and Acctg. Officer | 50,000 | $0 | 50,000 (Direct) | View |
| 2022-12-30 Disposition(A) | 2023-02-22 4:32 pm | N/A N/A | TherapeuticsMD Inc. | TXMD | Rubric Capital Management LP Rosen David Efraim See remarks 10% Owner | 29,000 | $1333 | 0 (Indirect) | View |
| 2022-12-08 Ownership | 2023-02-13 5:23 pm | N/A N/A | TherapeuticsMD Inc. | TXMD | Walker Marlan D Chief Executive Officer | 716 | $0 | 5,969 (Direct) | View |
| 2023-01-26 Exercise | 2023-01-30 6:40 pm | N/A N/A | TherapeuticsMD Inc. | TXMD | Donegan Michael C Prin. Fin. and Acctg. Officer | 5,940 | $0 | 11,853 (Direct) | View |
| 2023-01-23 Exercise | 2023-01-25 5:50 pm | N/A N/A | TherapeuticsMD Inc. | TXMD | Donegan Michael C Prin. Fin. and Acctg. Officer | 4,365 | $0 | 7,610 (Direct) | View |
| 2022-12-06 Exercise | 2022-12-09 7:41 pm | N/A N/A | TherapeuticsMD Inc. | TXMD | Bernick Brian Co-Chief Executive Officer | 3,167 | $0 | 49,596 (Direct) | View |
| 2022-12-06 Exercise | 2022-12-09 7:38 pm | N/A N/A | TherapeuticsMD Inc. | TXMD | Walker Marlan D General Counsel | 2,554 | $0 | 10,776 (Direct) | View |
| 2022-12-06 Exercise | 2022-12-09 7:38 pm | N/A N/A | TherapeuticsMD Inc. | TXMD | Glickman Mark A Co-Chief Executive Officer | 1,734 | $0 | 4,760 (Direct) | View |
| 2022-12-06 Exercise | 2022-12-09 7:37 pm | N/A N/A | TherapeuticsMD Inc. | TXMD | Donegan Michael C Interim CFO/CAO/VP of Finance | 3,476 | $0 | 6,519 (Direct) | View |
| 2022-09-29 Option Award | 2022-10-03 6:43 pm | N/A N/A | TherapeuticsMD Inc. | TXMD | Russell Angus C. Director | 5,000 | $0 | 5,000 (Direct) | View |
| 2022-09-29 Option Award | 2022-10-03 6:40 pm | N/A N/A | TherapeuticsMD Inc. | TXMD | BISARO PAUL Director | 5,000 | $0 | 5,000 (Direct) | View |
| 2022-09-29 Option Award | 2022-10-03 6:39 pm | N/A N/A | TherapeuticsMD Inc. | TXMD | Thompson Tommy G Director | 34,175 | $0 | 34,175 (Direct) | View |
| 2022-09-29 Option Award | 2022-10-03 6:39 pm | N/A N/A | TherapeuticsMD Inc. | TXMD | Collins Cooper C. Director | 5,000 | $0 | 5,000 (Direct) | View |
| 2022-09-29 Option Award | 2022-10-03 6:38 pm | N/A N/A | TherapeuticsMD Inc. | TXMD | Naughton Gail K Director | 5,000 | $0 | 5,000 (Direct) | View |
| 2022-09-29 Option Award | 2022-10-03 6:38 pm | N/A N/A | TherapeuticsMD Inc. | TXMD | MUSING JULES A. Director | 5,000 | $0 | 5,000 (Direct) | View |
| 2022-09-29 Option Award | 2022-10-03 6:38 pm | N/A N/A | TherapeuticsMD Inc. | TXMD | Ling Karen Director | 5,000 | $0 | 5,000 (Direct) | View |
Ownership | 2022-09-16 4:49 pm | N/A N/A | TherapeuticsMD Inc. | TXMD | Bernick Brian Co-Chief Executive Officer | 0 | $0 | 73,281 (Direct) | View |
| 2022-08-18 Exercise | 2022-08-22 06:00 am | N/A N/A | TherapeuticsMD Inc. | TXMD | Collins Cooper C. Director | 1,984 | $0 | 46,722 (Direct) | View |
| 2022-08-18 Exercise | 2022-08-22 06:00 am | N/A N/A | TherapeuticsMD Inc. | TXMD | Naughton Gail K Director | 1,984 | $0 | 3,922 (Direct) | View |
| 2022-08-18 Exercise | 2022-08-22 06:00 am | N/A N/A | TherapeuticsMD Inc. | TXMD | MUSING JULES A. Director | 1,984 | $0 | 4,022 (Direct) | View |
| 2022-08-18 Exercise | 2022-08-22 06:00 am | N/A N/A | TherapeuticsMD Inc. | TXMD | Russell Angus C. Director | 1,984 | $0 | 5,792 (Direct) | View |